Litcius/Paper detail

Phase 2a Study of Baxdrostat in Primary Aldosteronism

Adina F. Turcu, Mason W. Freeman, Irina Bancos, Anat Ben-Shlomo, Oksana Hamidi, Amir H. Hamrahian, Wenyu Huang, Lawrence S. Kirschner, Ramin Sam, Ashwini Mallappa, Bonifride Tuyishimire, Aina Sætre Lihn, Shira Perl, Morris J. Brown

2025New England Journal of Medicine38 citationsDOI

Abstract

In 15 patients with primary aldosteronism, baxdrostat (a second-generation, nonimidazole aldosterone synthase inhibitor) resolved or reduced the severity of hypertension, excessive aldosterone prod...

Topics & Concepts

Primary aldosteronismPrimary (astronomy)Phase (matter)HyperaldosteronismMedicineAldosteroneInternal medicineChemistryPhysicsOrganic chemistryAstronomyHormonal Regulation and HypertensionAdrenal and Paraganglionic TumorsEicosanoids and Hypertension Pharmacology
Phase 2a Study of Baxdrostat in Primary Aldosteronism | Litcius